about
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndromeThe pharmacological basis of opioidsEvolving paradigms in the treatment of opioid-induced bowel dysfunctionThe Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A ReviewClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionBiological redundancy of endogenous GPCR ligands in the gut and the potential for endogenous functional selectivityHIV, opiates, and enteric neuron dysfunctionNigella sativa (black cumin) seed extract alleviates symptoms of allergic diarrhea in mice, involving opioid receptorsChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenTreatment of opioid-induced gut dysfunctionThe Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A ReviewAcetylcholine serves as a derepressor in Loperamide-induced Opioid-Induced Bowel Dysfunction (OIBD) in zebrafishVgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.Lubiprostone reverses the inhibitory action of morphine on intestinal secretion in guinea pig and mouse.Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipationThe effects of daikenchuto (DKT) on propulsive motility in the colon.Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment.Basic and clinical pharmacology of new motility promoting agents.Thoracic Epidural analgesia versus Rectus Sheath Catheters for open midline incisions in major abdominal surgery within an enhanced recovery programme (TERSC): study protocol for a randomised controlled trial.The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.Promotility medications--now and in the future.Opiate-induced oesophageal dysmotility.Methylnaltrexone in the treatment of opioid-induced constipationDetection of drug effects on gastric emptying and contractility using a wireless motility capsule.Opioid receptors and associated regulator of G protein signaling are involved in the cathartic colon of rats.Opioid receptors in the gastrointestinal tract.Activation of μ opioid receptors modulates inflammation in acute experimental colitis.Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice.A pilot study of the nutritional status of opiate-using pregnant women on methadone maintenance therapyNeurochemical features of endomorphin-2-containing neurons in the submucosal plexus of the rat colonDistribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig.G Protein-Coupled Receptor Trafficking and Signalling in the Enteric Nervous System: The Past, Present and Future.Alvimopan, a selective peripherally acting mu-opioid antagonist.The narcotic bowel syndrome: clinical features, pathophysiology, and managementChronic methadone use, poor bowel visualization and failed colonoscopy: a preliminary study.Alvimopan for the management of postoperative ileus.Pharmacologic Agents for Chronic Diarrhea.Clinical management of pain in advanced lung cancer.
P2860
Q26743440-7D33667C-029F-4A54-9805-58BB118DA581Q26774405-4FE5A56C-AF8D-42D4-B3CD-363F982089D3Q26777692-CEEB7B5F-D8D8-4B11-8080-46886EBC0A7DQ26851158-E0E09CF6-EA01-4C86-AABC-E5E77889F3F0Q26995944-A46BC9F2-5F7C-4C4D-BDAB-D3F28B521F91Q27010907-C00EE4DE-61AA-4B08-AB4B-93FC39009EDDQ27021347-5AB00F7B-4250-4AF8-84A3-D339F49088FFQ27023420-66CBC5C8-C8DC-4513-8864-29541BF2B644Q27300141-113E7063-FCE5-4766-866A-042C5C2AFE70Q28079705-B6719A99-7247-4312-AD7E-A3F2B320F04CQ28209970-F182554E-7891-4838-80C5-52F7C31E150BQ28284578-F4BDE768-DC6F-42E9-9E88-29DBC9EF9087Q30235088-7D429918-D66E-4730-8F4E-A2A18C546136Q30582847-60FA6AF7-E463-4EBF-89FA-EDE105076BB8Q33296232-5E2BD36F-63C9-47CA-A94A-99CA380305D8Q34028142-456860E7-DDF3-49ED-B2F6-2B4D71F0A6D5Q34146166-F100FD89-3B84-4CB7-AC43-D4995F610435Q34154657-73DB2276-1363-44BE-8DAB-A9A45BEA3AAEQ34323667-7AAB4DC3-42E0-4806-B219-11ABE105F478Q34453951-C445CE02-0F33-46E7-883D-D5D518C7F1B6Q34469776-EE2E72E6-3CFB-4640-8606-960B49D511CBQ34478698-1827F54A-C38D-41ED-BFD5-A260259EC381Q34548916-72FD6401-8669-40C6-93EE-DB634A253816Q34973933-7F84CA09-B10D-448F-8E97-4EB0A13B9CF3Q35026245-363370C1-A769-4C19-8A35-D210A9051C4FQ35079522-658619F3-EEC4-4D57-9BF8-CE87DC2FD68BQ35159547-08171964-FDEF-471E-9533-A4EE5A803594Q35185222-D824715A-4208-4C88-B67D-85C742AB961EQ35510067-FCBA8B6A-450F-45FE-B69D-D6004615B330Q35601042-A05059B0-6DE9-4459-BE62-DFBC3765E021Q35671302-1D8E9021-0006-4F79-8C1D-796E71F938FAQ35778814-00BAA8FD-4E3D-4100-93D6-4E9EE6A16F9DQ36065514-B820C49D-1DFC-413C-AD6F-65A2CA84E0ACQ36068153-7DBFB05C-512C-445F-91EE-9B17A1009CC4Q36078760-AF0E07A6-C14F-4D61-91E3-DA26AA655784Q36136622-1383DFA2-211F-49A4-9F5A-EF9FE0CE1817Q36215519-8ABD06DC-344C-4249-9131-0999E1E2A38CQ36217219-5BDD7CF8-F86D-4E7F-9A04-6B907BFE7892Q36271715-48D38A54-0D0B-41CA-B062-E5F0E6AA5CE3Q36327481-702A8D69-DA09-4F7C-8307-6B4A25C7D932
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Function of opioids in the enteric nervous system.
@ast
Function of opioids in the enteric nervous system.
@en
type
label
Function of opioids in the enteric nervous system.
@ast
Function of opioids in the enteric nervous system.
@en
prefLabel
Function of opioids in the enteric nervous system.
@ast
Function of opioids in the enteric nervous system.
@en
P2860
P1476
Function of opioids in the enteric nervous system.
@en
P2093
Galligan JJ
P2860
P356
10.1111/J.1743-3150.2004.00554.X
P478
16 Suppl 2
P577
2004-10-01T00:00:00Z